Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Editor

Personal info

View

About

Terms

Javascript disabled

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Thomas Berg

Universitätsklinikum Charité

Campus Virchow-Klinikum

Universitätsmedizin Berlin

Berlin

Germany

[email]@charite.de

Name/email consistency: high

[Claim this account]

Affiliations

Universitätsklinikum Charité, Campus Virchow-Klinikum, Universitätsmedizin Berlin, Berlin, Germany. 2006 - 2009
Charite Universitatsmedizin Berlin, Berlin, Germany. 2008
Medizinische Klinik mit Schwerpunkt Hepatologie/Gastroenterologie, Universitätsklinikum Charité, Humboldt-Universität, Berlin, Germany. 1999 - 2003

References

Individualized treatment strategy according to early viral kinetics in hepatitis C virus type 1-infected patients. Berg, T., Weich, V., Teuber, G., Klinker, H., Möller, B., Rasenack, J., Hinrichsen, H., Gerlach, T., Spengler, U., Buggisch, P., Balk, H., Zankel, M., Neumann, K., Sarrazin, C., Zeuzem, S. Hepatology (2009) [Pubmed]
Optimizing outcomes in patients with hepatitis C virus genotype 2 or 3. Berg, T., Carosi, G. Antivir. Ther. (Lond.) (2008) [Pubmed]
Tailored treatment for hepatitis C. Berg, T. Clin. Liver. Dis (2008) [Pubmed]
Extended treatment duration for hepatitis C virus type 1: comparing 48 versus 72 weeks of peginterferon-alfa-2a plus ribavirin. Berg, T., von Wagner, M., Nasser, S., Sarrazin, C., Heintges, T., Gerlach, T., Buggisch, P., Goeser, T., Rasenack, J., Pape, G.R., Schmidt, W.E., Kallinowski, B., Klinker, H., Spengler, U., Martus, P., Alshuth, U., Zeuzem, S. Gastroenterology (2006) [Pubmed]
Triple therapy with amantadine in treatment-naive patients with chronic hepatitis C: a placebo-controlled trial. Berg, T., Kronenberger, B., Hinrichsen, H., Gerlach, T., Buggisch, P., Herrmann, E., Spengler, U., Goeser, T., Nasser, S., Wursthorn, K., Pape, G.R., Hopf, U., Zeuzem, S. Hepatology (2003) [Pubmed]
Distinct enzyme profiles in patients with cryptogenic cirrhosis reflect heterogeneous causes with different outcomes after liver transplantation (OLT): a long-term documentation before and after OLT. Berg, T., Neuhaus, R., Klein, R., Leder, K., Lobeck, H., Bechstein, W.O., Müller, A.R., Wiedenmann, B., Hopf, U., Berg, P.A., Neuhaus, P. Transplantation (2002) [Pubmed]
Pilot study of interferon-alpha high-dose induction therapy in combination with ribavirin plus amantadine for nonresponder patients with chronic hepatitis C. Berg, T., Naumann, U., Wiedenmann, B., Hopf, U. Z. Gastroenterol (2001) [Pubmed]
Mutations in the E2-PePHD and NS5A region of hepatitis C virus type 1 and the dynamics of hepatitis C viremia decline during interferon alfa treatment. Berg, T., Mas Marques, A., Höhne, M., Wiedenmann, B., Hopf, U., Schreier, E. Hepatology (2000) [Pubmed]
Efficacy of a short-term ribavirin plus interferon alpha combination therapy followed by interferon alpha alone in previously untreated patients with chronic hepatitis C: a randomized multicenter trial. Berg, T., Hoffmann, R.M., Teuber, G., Leifeld, L., Lafrenz, M., Baumgarten, R., Spengler, U., Zeuzem, S., Pape, G.R., Hopf, U. Liver (2000) [Pubmed]
Occurrence of a novel DNA virus (TTV) infection in patients with liver diseases and its frequency in blood donors. Berg, T., Schreier, E., Heuft, H.G., Höhne, M., Bechstein, W.O., Leder, K., Hopf, U., Neuhaus, P., Wiedenmann, B. J. Med. Virol. (1999) [Pubmed]

The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.